Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: Identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection

Long,Jiang; Wang,Yan; Li,Man; Tong,Wei-Min; Jia,Ji-Dong; Huang,Jian

doi:10.3892/or.2013.2430

Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: Identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection

Authors:
- Jiang Long
- Yan Wang
- Man Li
- Wei-Min Tong
- Ji-Dong Jia
- Jian Huang
View Affiliations

Affiliations: Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China, Department of Pathology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
Published online on: April 26, 2013 https://doi.org/10.3892/or.2013.2430
Pages: 119-124

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although it is known that chronic hepatitis C virus (HCV) infection may contribute to tumor initiation and development, the molecular processes causing hepatocellular carcinoma (HCC) remain unclear. Microindels are unique, infrequent mutations that result in inserted and deleted sequences at the same nucleotide position, and are important contributors to cancer. To date, microindels in the p53 tumor suppressor gene (TP53) have not been fully examined in tumors. In the present study, 116 cases of HCC were screened for mutations in the TP53 gene (exon 5-8) by single-stranded conformational polymorphism analysis followed by direct sequencing. A special type of complex TP53 mutation, 616ins14del1 (14-1 microindel), was identified in a case of HCC with HCV infection. This rare TP53 microindel led to the generation of a truncated protein of 211 amino acids that lacked the DNA-binding domain and tetramerization domain. Immunohistochemistry showed loss of p53 protein expression and downregulation of p21WAF/CIP, Mdm2 and Bax in the tumor cells, indicating an impaired p53 signaling pathway. Nineteen of the 116 (16.4%) HCCs carried a total of 19 TP53 mutations. Notably, 5 of the 13 HCV-positive (38.5%) cases contained a TP53 mutation, and there was a significant association between TP53 mutations and HCV positivity (P=0.0379). No correlation of TP53 mutations with hepatitis B virus (HBV) positivity was observed. In summary, we identified a novel TP53 microindel in HCC, and provided evidence of HCC characterized by HCV infections typically associated with mutational inactivation of the TP53 gene.

View Figures

View References

1	Thorgeirsson SS and Grisham TW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
2	Perz JF, Armstrong GL, Farrington LA, Hutin YJ and Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatology. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
3	Raza SA, Clifford GM and Franceschi S: Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer. 96:1127–1134. 2007. View Article : Google Scholar : PubMed/NCBI
4	Liang TJ and Heller T: Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology. 127:S62–S71. 2004. View Article : Google Scholar : PubMed/NCBI
5	Mínguez B, Tovar V, Chiang D, Villanueva A and Llovet J: Pathogenesis of hepatocellular carcinoma and molecular therapies. Curr Opin Gastroenterol. 25:186–194. 2009.PubMed/NCBI
6	Ozturk M: p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet. 338:1356–1359. 1991. View Article : Google Scholar : PubMed/NCBI
7	Hussain SP, Schwank J, Staib F, Wang XW and Harris CC: TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 26:2166–2176. 2007. View Article : Google Scholar : PubMed/NCBI
8	Chen GG, Merchant JL, Lai PBS, et al: Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89. Am J Pathol. 162:1823–1829. 2003. View Article : Google Scholar : PubMed/NCBI
9	Gonzalez KD, Hill KA, Li K, et al: Somatic microindels: analysis in mouse soma and comparison with the human germline. Hum Mutat. 28:69–80. 2007. View Article : Google Scholar : PubMed/NCBI
10	Hill KA, Gonzalez KD, Scaringe WA, Wang JC and Sommer SS: Preferential occurrence of 1–2 microindels. Hum Mutat. 27:55–61. 2006.
11	Huang J, Grotzer MA, Watanabe T, Watanabe T, Hewer E, Pietsch T, Rutkowski S and Ohgaki H: Mutations in the Nijmegen breakage syndrome gene in medulloblastomas. Clin Cancer Res. 14:4053–4058. 2008. View Article : Google Scholar : PubMed/NCBI
12	Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1233–1238. 1990. View Article : Google Scholar : PubMed/NCBI
13	Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 28:622–629. 2007. View Article : Google Scholar : PubMed/NCBI
14	Bressac B, Katherine M, Galvin T, Liang J, Isselbacher KJ, Wands JR and Ozturk M: Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1973–1977. 1990. View Article : Google Scholar : PubMed/NCBI
15	Boyault S, Rickman DS, Reynies AD, et al: Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 45:42–52. 2007. View Article : Google Scholar : PubMed/NCBI
16	Wardelmann E, Merkelbach-Bruse S, Pauls K, et al: Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate. Clin Cancer Res. 12:1743–1749. 2006. View Article : Google Scholar
17	Scaringe WA, Li K, Gu DQ, Gonzalez KD, Chen ZB, Hill KA and Sommer SS: Somatic microindels in human cancer: the insertions are highly error-prone and derive from nearby but not adjacent sense and antisense templates. Hum Mol Genet. 17:2910–2918. 2008. View Article : Google Scholar : PubMed/NCBI
18	Noensie EN and Dietz HC: A strategy for disease gene identification through nonsense mediated mRNA decay inhibition. Nat Biotechnol. 19:434–439. 2001. View Article : Google Scholar : PubMed/NCBI
19	Bouchard MJ and Navas-Martin S: Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenge. Cancer Lett. 305:123–143. 2011. View Article : Google Scholar : PubMed/NCBI
20	Bassiouny AE, Nosseir MM, Zoheiry MK, et al: Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World J Hepatol. 2:32–41. 2010.PubMed/NCBI
21	Okada T, Iizuka N, Yamada-Okabe H, et al: Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma. FEBS Lett. 555:583–590. 2003. View Article : Google Scholar : PubMed/NCBI
22	Machida K, Cheng KT, Sung VM, et al: Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and proto-oncogenes. Proc Natl Acad Sci USA. 101:4262–4267. 2004. View Article : Google Scholar : PubMed/NCBI
23	Anzola M and Burgos JJ: Hepatocellular carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis. Expert Rev Mol Med. 5:1–16. 2003. View Article : Google Scholar : PubMed/NCBI
24	Chang MH, Chen CJ, Lai MS, et al: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 336:1855–1859. 1997. View Article : Google Scholar : PubMed/NCBI
25	Guichard C, Amaddeo G, Imbeaud S, et al: Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 44:694–698. 2012. View Article : Google Scholar : PubMed/NCBI
26	Jiang S, Yang Z, Li W, et al: Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. Plos One. 7:e403632012. View Article : Google Scholar : PubMed/NCBI